Viewing Study NCT05184335


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-25 @ 7:51 PM
Study NCT ID: NCT05184335
Status: RECRUITING
Last Update Posted: 2024-12-19
First Post: 2021-11-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module